Acadia Healthcare Company, Inc.: management transactions · United States · SEC (Form 4)

About Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. (ticker: ACHC) is a U.S.-listed company traded on the NYSE in the United States and focused on behavioral health services. Founded in January 2005, Acadia was built to develop and operate a national network of facilities addressing psychiatric disorders, substance use disorders, and related specialty behavioral health needs. The company is headquartered in Franklin, Tennessee, United States, giving it a domestic operating base in one of the most important and structurally underserved segments of U.S. healthcare. Acadia’s business model centers on a broad mix of care settings rather than a single product line. Its portfolio includes acute inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers, outpatient clinics, and school-based or community-oriented behavioral health programs. This multi-acuity platform allows the company to serve patients across the full continuum of care, from crisis intervention and inpatient stabilization to longer-term rehabilitation and outpatient follow-up. In practical terms, Acadia is not a pharmaceutical or device company; it is a services operator whose revenues depend on patient volumes, payer mix, staffing, bed capacity, and utilization across its network. From a competitive standpoint, Acadia holds a meaningful position in a fragmented U.S. behavioral health market. Its scale gives it a recognizable footprint with payors, referral sources, hospitals, and public-sector partners, while also supporting operational leverage across its platform. The company has described itself as the largest stand-alone behavioral health company in the U.S., which underscores its niche leadership. That said, the sector remains highly regulated and operationally demanding. Key challenges include reimbursement pressure, labor availability, compliance requirements, litigation risk, and sensitivity to changes in government funding, particularly Medicaid-related policy. Geographically, Acadia’s operations are concentrated in the United States, with a footprint spanning many states and Puerto Rico. Recent company disclosures indicate continued expansion of its facility network into 2025 and 2026, reflecting ongoing investment in capacity, de novo development, and acquisitions. Recent SEC filings and company communications also highlight management’s focus on operational execution, financial performance, and exposure to policy changes affecting behavioral health reimbursement. For investors, ACHC represents a U.S. healthcare services name with secular demand tailwinds from rising mental health and addiction-treatment needs, but also with elevated execution and regulatory risk typical of the sector.